Annual Congress Stockholm 2002

Saturday, 14.09.2002
Sunday, 15.09.2002
Monday, 16.09.2002
Tuesday, 17.09.2002
Wednesday, 18.09.2002

Citations should be made in the following way: Authors. Title. Eur Respir J 2002; 20: Suppl. 38, abstract number.

Material from 2002:

3388 Abstracts
6 Slide presentations
5 Handouts

Material from 2002: Show

New anti-inflammatory agents for asthma and COPD

Oral Presentation
Chairs: K. F. Rabe (Leiden, The Netherlands), H. Milgrom (Denver, United States of America)

Download all media

A comparison of suplatast tosilate, a Th2 cytokine inhibitor, and inhaled fluticasone propionate for airway inflammation in mild asthma J. Tamaoki, K. Isono, M. Kondo, T. Takizawa, A. Nagai (Tokyo, Kurihashi, Japan)
Anti-inflammatory properties of nimesulide and clarithromycin: a comparative study during the therapy of bronchial sepsis involving P.aeruginosa G. V. Shmarina, A. L. Pukhalsky, S. N. Kokarovtseva, N. I. Kapranov, L. A. Shabalova (Moscow, Russia)
The effect of heparin nebulization on BAL cellularity and clinical evaluation in a long-time study in patients with bronchial asthma A. M. Fal, M. Krasnowska, J. Miecielica, A. Kwasniewski, A. Obojski, J. Malolepszy (Wroclaw, Poland)
Study of the Glutoxim-containing inhalation treatment in bronchial asthma patients M. A. Zaitseva, L. A. Kozhemyakin, T. E. Gembitskaya, A. V. Molodtsova (St-Petersburg, Russia)
Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study K. R. Chapman, P. Patel, L. P. Boulet, A. D. D'Urzo, M. Alexander, S. Mehra, C. Oedekoven (Toronto, Mississauga, Sainte-Foy, Niagara Falls, Oshawa, Canada; Konstanz, Germany)
Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis F. S. F. Ram, S. Cendon (London, United Kingdom; Sau Paulo, Brazil)
Roflumilast, a new orally active phosphodiesterase 4 inhibitor, is effective in the treatment of chronic obstructive pulmonary disease D. Bredenbröker, J. Syed, S. Leichtl, F. Rathgeb, W. Wurst (Konstanz, Germany)
N-acetylcysteine for the treatment of acute exacerbations of COPD P. N. Black, A. Morgan-Day, T. E. Picton, P. J. Poole, R. P. Young, J. Stewart (Auckland, New Zealand)